Clinical Trial

Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this research is to assess whether the use of a topical cream with an active ingredient can reduce the amount of foot pain experienced in participants who have been diagnosed with Diabetic Peripheral Neuropathy (DPN) with minimal side effects or discomfort from use.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-01.
Status change: Not Yet Recruiting → Recruiting 2026-04-15
Trial Details
NCT Number NCT07260656
Lead Sponsor Carilion Clinic
Conditions Diabetic Neuropathies, Painful, Diabetic Foot, Diabetic Peripheral Neuropathy
Enrollment 80 participants
Start Date 2025-11-26
Primary Completion 2027-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-04-20